Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests.

Genes - 3 Mar 2021

Tafazoli Alireza, Guggilla Rama Krishna, Kamel-Koleti Zahra, Miltyk Wojciech

Abstract excerpt

Direct-to-consumer genetic tests (DTC-GT) have become a bridge between marketing and traditional healthcare services. After earning FDA endorsement for such facilities, several fast-developing companies started to compete in the related area. Pharmacogenomic (PGx) tests have been introduced as potentially one of the main medical services of such companies. Most of the individuals will be interested in finding out...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Pharmacogenetics
Share to Pharmacogenomic Variants
Share to Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 33802585
DOI: 10.3390/genes12030361
PMCID: PMC7999840

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests.PMID 33802585Read ↗

The future of direct-to-consumer clinical genetic testsSemantic proximity Read ↗

Theranostics in primary care: pharmacogenomics tests and beyond.Semantic proximity Read ↗

Statement of the ESHG on direct-to-consumer genetic testing for health-related purposesSemantic proximity Read ↗

Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMeSemantic proximity Read ↗

The past, present, and future of direct-to-consumer genetic tests.Semantic proximity Read ↗

Direct-to-consumer genetic testing: access and marketing.Semantic proximity Read ↗

Emerging strategies and applications of pharmacogenomics.Semantic proximity Read ↗

Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe.Semantic proximity Read ↗

Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.Semantic proximity Read ↗

Current State and Future Prospects of Direct-to-Consumer PharmacogeneticsSemantic proximity Read ↗

Clinically available pharmacogenomics tests.Semantic proximity Read ↗

Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.